RXRX - Director of Recursion Pharmaceuticals Sold $58K In Stock | Benzinga
Blake Borgeson, Director at Recursion Pharmaceuticals (NASDAQ:RXRX), reported a large insider sell on October 19, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Borgeson sold 8,885 shares of Recursion Pharmaceuticals. The total transaction amounted to $58,482.
Recursion Pharmaceuticals shares are trading down 0.83% at $6.0 at the time of this writing on Friday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, however an ...